TUCCORI, Marco
 Distribuzione geografica
Continente #
AS - Asia 1.882
NA - Nord America 1.257
EU - Europa 777
SA - Sud America 338
AF - Africa 44
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.302
Nazione #
US - Stati Uniti d'America 1.201
SG - Singapore 960
HK - Hong Kong 395
BR - Brasile 293
CN - Cina 224
IT - Italia 154
GB - Regno Unito 141
KR - Corea 139
DE - Germania 98
RU - Federazione Russa 67
FI - Finlandia 59
VN - Vietnam 57
FR - Francia 56
NL - Olanda 47
SE - Svezia 45
IE - Irlanda 31
MX - Messico 26
AT - Austria 20
IN - India 19
BD - Bangladesh 18
CA - Canada 16
AR - Argentina 15
ZA - Sudafrica 15
ES - Italia 14
JP - Giappone 14
TR - Turchia 11
UA - Ucraina 11
IQ - Iraq 8
CO - Colombia 7
PL - Polonia 7
MA - Marocco 6
TG - Togo 6
UZ - Uzbekistan 6
BG - Bulgaria 5
IL - Israele 5
PY - Paraguay 5
SA - Arabia Saudita 5
CL - Cile 4
EC - Ecuador 4
GR - Grecia 4
KE - Kenya 4
VE - Venezuela 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
ID - Indonesia 3
LV - Lettonia 3
ME - Montenegro 3
PK - Pakistan 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CG - Congo 2
EG - Egitto 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
RE - Reunion 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
IS - Islanda 1
KW - Kuwait 1
MG - Madagascar 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.302
Città #
Singapore 414
Hong Kong 394
Dallas 388
Southend 110
Jacksonville 87
Chandler 76
Verona 66
Ashburn 61
Houston 47
Woodbridge 45
New York 43
Beijing 34
Los Angeles 32
Helsinki 31
Amsterdam 30
The Dalles 29
Dublin 28
São Paulo 22
Ho Chi Minh City 21
Mexico City 18
Nuremberg 17
Munich 16
Lawrence 15
Princeton 15
Jinan 13
Johannesburg 12
Chicago 11
Falkenstein 11
Hanoi 11
Nanjing 10
Vienna 10
Columbus 9
Pisa 9
Sindelfingen 9
Tianjin 9
Belo Horizonte 8
Hebei 8
Redmond 8
Rome 8
Shanghai 8
Wilmington 8
Atlanta 7
Brooklyn 7
Denver 7
Dhaka 7
Messina 7
Moscow 7
San Francisco 7
Santa Clara 7
Seattle 7
Seoul 7
Taizhou 7
Boston 6
Brasília 6
Falls Church 6
Frankfurt am Main 6
Istanbul 6
Lomé 6
Rio de Janeiro 6
Stockholm 6
Warsaw 6
Zhengzhou 6
Bologna 5
Guarulhos 5
Haikou 5
Manchester 5
Nanchang 5
Norwalk 5
Sofia 5
Tashkent 5
Tokyo 5
Campinas 4
Caçapava 4
Changsha 4
Charlotte 4
Chennai 4
Florence 4
Hangzhou 4
Madrid 4
Milan 4
Montreal 4
Mumbai 4
Nairobi 4
Ningbo 4
Phoenix 4
Recife 4
Santa Maria 4
Santo André 4
Turku 4
Asunción 3
Baghdad 3
Boydton 3
Buenos Aires 3
Buffalo 3
Caxias do Sul 3
Contagem 3
Fuzhou 3
Giv‘atayim 3
Lahore 3
Lancaster 3
Totale 2.488
Nome #
Cutaneous drug reactions: data from an Italian spontaneous reporting database 121
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 114
Allergic reactions to oral drugs: a case/non case study from an Italian spontaneous reports database. 113
Detecting adverse drug reactions caused by drug-drug interaction in a spontaneous reporting database 107
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 106
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 104
Allergic reactions to oral drugs: a case/non case study from an Italian spontaneous reporting database (GIF) 101
Identificazione di interazioni farmacologiche gravi in un database di segnalazione spontanea 83
International Trends in Opioid Prescribing by Age and Sex from 2001 to 2019: An Observational Study Using Population-Based Databases from 18 Countries and One Special Administrative Region 82
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database 76
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 75
Statin-associated psychiatric adverse events: a case/non case evaluation of an Italian Database of Spontaneous reporting of adverse drug reactions 73
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives 72
Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy 70
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting 68
Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting 63
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review 58
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 55
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems 50
Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 50
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project 48
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration 44
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 38
Monoclonal antibody therapies against SARS-CoV-2 38
Allopurinol adherence among patients with gout: an Italian general practice database study 37
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network 36
FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception 35
Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis 35
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement 32
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 31
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 31
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy 30
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 30
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 29
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 29
Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance 29
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project 29
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 28
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 28
Acute myocardial infarction following off label retrobulbar injection of desmopressin for non-arteritic anterior ischemic optic neuropathy (NAION). Causal correlation or coincidence? 27
ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity 27
Effects of a bicarbonate-alkaline water on digestive motility in experimental models of functional gastrointestinal disorders 27
Authors’ response: Inhibiting IL-6 in COVID-19: we are not sure that sgp130(fc) can affect only the trans-signaling receptor pathway of IL-6 26
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy 26
Role of A2a adenosine in the regulation of colonic motility in normal human colon 26
A(1) and A(2a) receptors mediate inhibitory effects of adenosine on the motor activity of human colon 26
Acute severe myopathy following single intravenous infusion of omeprazole 25
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care 25
Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases 25
Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy 25
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature 24
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 24
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation 24
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 24
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 24
Pioglitazone use and risk of bladder cancer: population based cohort study 23
Control of enteric neuromuscular functions by A3 purinergic receptors in normal rat distal colon and experimental bowel inflammation 23
Mechanisms of protection by pantoprazole againist NSAID-induced gastric mucosal damaged 23
A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric 'purinome' concept 23
Safety and effectiveness of direct oral anticoagulants versus vitamin K antagonists: results from 3 Italian regions 23
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 23
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 23
Progressive multifocal leukoencephalopathy: what's new? 23
The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in Italy 23
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 22
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 22
RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome 22
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 22
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 22
SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies 22
Convalescent Plasma Therapy for COVID-19: State of the Art 22
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward 22
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 21
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 21
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 21
Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world 21
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies 21
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 21
Tolerability profiles of leukotriene receptor antagonists and long-acting β2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma. A review 21
Safety concerns associated with the use of serotonin reuptake and other serotonergic/noradrenergic antidepressants during pregnancy: a review 21
Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance 21
Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery 21
Pharmacological Modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 21
The usefulness of listening social media for pharmacovigilance purposes: a systematic review 20
Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review 20
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 20
Serotonin syndrome and the T102 → C polymorphism of the 5-HT2A receptor: a case report 20
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 20
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 20
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis 20
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 20
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? 20
Potentially inappropriate drug use in myasthenia gravis: a real-world population-based cohort study in Italy 20
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 20
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat 20
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 20
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 20
Drug Use Patterns in Myasthenia Gravis: A Real-World Population-Based Cohort Study in Italy 19
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms 19
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks 19
Totale 3.634
Categoria #
all - tutte 20.421
article - articoli 18.363
book - libri 0
conference - conferenze 2.058
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 2 12 23 8 3 9 11 0 9 5
2021/2022124 12 23 0 11 29 4 3 7 4 2 8 21
2022/2023239 17 19 22 40 18 45 4 19 17 2 21 15
2023/2024176 7 9 14 18 18 33 12 14 1 22 14 14
2024/20252.149 17 32 54 81 250 159 95 83 346 158 279 595
2025/20261.359 600 401 358 0 0 0 0 0 0 0 0 0
Totale 4.489